FDA Reopens Comment Period on Proposed Labeling Regulations for “Conventional Foods” & Dietary Supplements

October 22, 2015

On March 3, 2014, FDA announced a proposed rule that would amend the regulations regarding the labeling of conventional foods and dietary supplements. In this announcement, the Agency sought feedback by asking the public for comment on its proposal.

According to FDA’s definition, a dietary supplement is “a product taken by mouth that is intended to supplement the diet and that contains one or more ‘dietary ingredients,’” which could include:

FDA requires any product identifying as a “dietary supplement” to be labeled as such and cannot be “represented for use as a conventional food or as the sole item of a meal or the diet.” Conventional food products are different from dietary supplements and are required to have a “Nutrition Facts” panel on their label, whereas dietary supplements have a “Supplement Facts” panel. One way FDA says one way to differentiate between dietary supplements and conventional foods, is by looking at the labels of the respective products.

In July of 2015, FDA issued a supplemental proposed rule and reopened the comment period until September 25th. The purpose of this was only to obtain comments on “two consumer studies being added to the administrative record.” Then on September 10, 2015, FDA issued a notice in which they clarified the following points:

  1. “The consumer studies on the added sugars declaration and the alternative footnote statements in the supplemental proposal relate to topics on which we sought comment
  2. The consumer studies on the format published in a separate notice in July 2015 were included for comment, and were placed in the docket at that time.”

FDA also stated in the notice that “in response to requests for the raw data for each of these consumer studies that are relevant to the summary memoranda for the studies,” it would be making the raw data available for comment as well. At that time, the Agency extended the comment period for the two consumer studies related to the proposed changes to the Nutrition Facts label formats (which was originally scheduled to close on September 25, 2015) to October 13, 2015, to coincide with the end of the comment period for the supplemental proposed rule.

However, on October 13 and 14, the Federal eRulemaking Portal experienced technical difficulties in which prevented the electronic submission of some comments. Because of this technical glitch, on October 20, 2015, in an announcement in the Federal Register, the Agency stated that the comment period for both the consumer studies and the supplemental proposal would be reopened until October 23, 2015.

If interested in providing the Agency with input on the proposed regulation, submit your comments here.

Do you have a dietary supplement or a conventional food product? We can help ensure that you are compliant with labeling regulations in addition to all other FDA regulations regarding these types of products. For more information on how we can help you, please contact us.

Agency Alerts General Regulatory

April 18, 2016

FDA Reopens Comment Period for Proposed Rule Regarding Regulation of Fixed-Combination Drugs

On December 23, 2015, the FDA announced a proposed rule regarding the regulation of fixed-combination drugs. In its announcement, FDA proposed that its requirements for prescription fixed-combination...

Read the Full Article
Agency Alerts General Regulatory

May 4, 2016

FDA Guidelines for Post-Approval CMC Changes, Part Two: Contents of Comparability Protocol Submissions

Additional information on FDA's draft guidance is available in our preceding FDA News article, entitled "FDA Guidelines for Post-Approval CMC Changes, Part One: Overview of the Updated Draft...

Read the Full Article
Agency Alerts General Regulatory

January 5, 2016

Best Practices for Meeting-Related Communication with FDA

In December 2015, the FDA released a draft guidance, which provides IND sponsors with a number of recommendations and best practices for communicating with the FDA. Among those included in the draft...

Read the Full Article